The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated

Background Mental comorbidity is common in multiple sclerosis (MS), but some studies suggest that mental comorbidity may be underrecognized and undertreated. Objective Using the North American Research Committee on MS Registry, we assessed the frequency of mental comorbidities in MS and sociodemographic characteristics associated with diagnosis and treatment of depression. Methods We queried participants regarding depression, anxiety, bipolar disorder, and schizophrenia. Depressive symptoms were assessed using the Center for Epidemiologic Studies Depression Scale (CESD); a score ≥21 indicated probable major depression. Results Mental comorbidity affected 4264 (48%) responders; depression most frequently (4012, 46%). Among participants not reporting mental comorbidity, 751 (16.2%) had CESD scores ≥21 suggesting undiagnosed depression. Lower socioeconomic status was associated with increased odds of depression (Income $15,000–30,000 vs >$100,000 OR 1.34; 1.11–1.62), undiagnosed depression (Income $15,000–30,000 vs >$100,000 OR 1.52; 1.08–2.13), and untreated depression (<high school vs postgraduate degree OR 3.13; 1.65–5.99). Conclusions Mental comorbidity remains underdiagnosed and undertreated in MS. Patients of lower socioeconomic status bear a disproportionate share of the burden of depression.

[1]  G Cutter,et al.  Comorbidity, socioeconomic status and multiple sclerosis , 2008, Multiple sclerosis.

[2]  R. Marrie,et al.  Validation of the NARCOMS registry: diagnosis , 2007, Multiple sclerosis.

[3]  A. Feinstein,et al.  Anxiety disorders and their clinical correlates in multiple sclerosis patients , 2007, Multiple sclerosis.

[4]  C. Papageorgiou,et al.  Associations of the Expanded Disability Status Scale with anxiety and depression in multiple sclerosis outpatients , 2007, Acta neurologica Scandinavica.

[5]  D. Mohr,et al.  Treatment of depression for patients with multiple sclerosis in neurology clinics , 2006, Multiple sclerosis.

[6]  M. Hutchinson,et al.  Unrecognised symptoms of depression in a community–based population with multiple sclerosis , 2006, Journal of Neurology.

[7]  D. Shabas,et al.  Multiple sclerosis management for low-income minorities , 2005, Multiple sclerosis.

[8]  Olga V. Demler,et al.  The Prevalence and Correlates of Nonaffective Psychosis in the National Comorbidity Survey Replication (NCS-R) , 2005, Biological Psychiatry.

[9]  S. Patten,et al.  Psychotic disorders in MS: Population-based evidence of an association , 2005, Neurology.

[10]  Hyon K. Choi,et al.  Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. , 2005, The Journal of rheumatology.

[11]  Deborah M. Miller,et al.  The Goldman Consensus statement on depression in multiple sclerosis , 2005, Multiple sclerosis.

[12]  S. Patten,et al.  Predictive value of the CES-D in detecting depression among candidates for disease-modifying multiple sclerosis treatment. , 2005, Psychosomatics.

[13]  J. Haselkorn,et al.  Prevalence and correlates of depression among veterans with multiple sclerosis , 2005, Neurology.

[14]  C. Constantinescu,et al.  A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic , 2004, Multiple sclerosis.

[15]  Lorena Hsu,et al.  Prevalence and Incidence Studies of Anxiety Disorders: A Systematic Review of the Literature , 2004, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[16]  Olga V. Demler,et al.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). , 2003, JAMA.

[17]  M. Liang,et al.  The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. , 2003, Arthritis and rheumatism.

[18]  D. Ehde,et al.  Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. , 2002, The American journal of psychiatry.

[19]  A. Feinstein An examination of suicidal intent in patients with multiple sclerosis , 2002, Neurology.

[20]  W. Katon,et al.  Depressive symptoms and mortality in a prospective study of 2,558 older adults. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[21]  S. Woods,et al.  The economic burden of bipolar disease. , 2000, The Journal of clinical psychiatry.

[22]  J. Fisk,et al.  Hospital-based Psychiatric Service Utilization and Morbidity in Multiple Sclerosis , 1998, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[23]  D. Mohr,et al.  Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. , 1997, Archives of neurology.

[24]  R Yancik,et al.  Cancer and comorbidity in older patients: a descriptive profile. , 1996, Annals of epidemiology.

[25]  R. Bland,et al.  Psychiatric Manifestations of Multiple Sclerosis: A Review , 1996, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[26]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[27]  R. Joffe,et al.  Mood disorder and multiple sclerosis. , 1987, Archives of neurology.

[28]  M. Weissman,et al.  Assessing depressive symptoms in five psychiatric populations: a validation study. , 1977, American journal of epidemiology.

[29]  J. Suvisaari,et al.  Lifetime prevalence of psychotic and bipolar I disorders in a general population. , 2007, Archives of general psychiatry.

[30]  C. Schoenborn,et al.  Age adjustment using the 2000 projected U.S. population. , 2001, Healthy People 2010 statistical notes : from the Centers for Disease Control and Prevention/National Center for Health Statistics.

[31]  M. Thase,et al.  Diagnostic certainty of a voluntary bipolar disorder case registry. , 1999, Journal of affective disorders.